Fibroblast growth factor 8 (FGF-8) is a secreted heparinbinding protein, which has transforming potential. Alternative splicing of the mouse Fgf-8 gene potentially codes for eight protein isoforms (a ± h) which dier in their transforming capacity in transfected cells. S115 mouse mammary tumor cells express a transformed phenotype and secrete FGF-8 in an androgen-dependent manner. In order to study the role of FGF-8 isoforms in the induction of transformed phenotype of breast cancer cells, we over-expressed FGF-8 isoforms a, b and e in S115 cells. Over-expression of FGF-8b, but not FGF-8a or FGF-8e, induced androgen and anchorage independent growth of S115 cells. FGF-8b-transfected S115 cells formed rapidly growing tumors with increased vascularization when injected s.c. into nude mice. FGF-8a also slightly increased tumor growth and probably tumor vascularization but FGF-8e was not found to have any eects. The angiogenic activity of FGF-8b and heparinbinding growth factor fraction (HBGF) of S115 cell conditioned media was tested in in vitro and in vivo models for angiogenesis using immortomouse brain capillary endothelial cells (IBEC) and chorion allantoic membrane (CAM) assays. Recombinant FGF-8b protein was able to stimulate proliferation, migration, and vessellike tube formation of IBECs. In addition, stimulatory eect of S115-HBGF on IBE cell proliferation was evident. A positive angiogenic response to FGF-8b was also seen in CAM assay. The results demonstrate that the expression of Fgf-8b is able to promote vessel formation. Angiogenic capacity probably markedly contributes to the ability of FGF-8b to increase tumor growth of androgen-regulated S115 mouse breast cancer cells. Oncogene (2001) 20, 2791 ± 2804.
Introduction
Fibroblast growth factors form a family of at least 23 structurally related growth-regulatory proteins (Szebenyi and Fallon, 1999; Yamashita et al., 2000) . They induce proliferation and dierentiation in a wide range of cells of epithelial, mesodermal and neuroectodermal origin. FGF-8, originally cloned as an androgeninduced growth factor (Tanaka et al., 1992) , has an important role in embryo-and organogenesis during gastrulation, brain development, and limb and facial morphogenesis (Heikinheimo et al., 1994; Crossley and Martin, 1995; Crossley et al., 1996a,b; Lewandoski et al., 1997) . In adult mouse, FGF-8 expression has been detected only in ovary and testis (Lorenzi et al., 1995; MacArthur et al., 1995c; Valve et al., 1997) . FGF-8 is also expressed in human mammary gland and prostate but at a very low level (Ghosh et al., 1996; Tanaka et al., 1998; Marsh et al., 1999) . Alternative splicing of Fgf-8 gene gives rise to potentially eight dierent protein isoforms (a ± h) in the mouse and four (a, b, e, f) in the human, diering in the amino terminus (Crossley and Martin, 1995; MacArthur et al., 1995b; Gemel et al., 1996) . The functional signi®cance of these dierent isoforms is not known. They dier, however, at least in transforming potential, FGF-8b having the highest transforming activity in NIH3T3 cells (MacArthur et al., 1995a; Ghosh et al., 1996) .
Fgf-8 has been identi®ed as an oncogene on the basis of over-expression of Fgf-8 in NIH3T3 cells (Kouhara et al., 1994) . Previously, we have found that the expression of Fgf-8 in S115 cells is most probably insertionally activated by integration of MMTV (mouse mammary tumor virus) proviral sequences containing steroid-regulated LTR promoters (Valve et al., 1998) . Fgf-8 has also been reported to be activated by MMTV integration in Wnt-1 transgenic mice (MacArthur et al., 1995c) . The generation of Fgf-8 transgenic mice utilizing the MMTV promoter has been shown to produce mammary lobular adenocarcinomas, salivary gland tumors and ovarian stromal hyperplasia (Daphna-Iken et al., 1998) . In addition, the expression of FGF-8 mRNA has been found in human breast cancer and in dierent human breast cancer cell lines Johnson et al., 1998; Marsh et al., 1999) . FGF-8 is actually the only member of the FGF family, which is known to be expressed at an elevated level in breast cancer . Over-expression of FGF-8 has also been observed in prostate cancer and is associated with a decreased survival of prostate cancer patients (Dorkin et al., 1999) . Taken together, these data suggest that FGF-8 has an important role in tumorigenesis and in progression of hormonal cancers.
Several studies suggest that tumor growth and progression are closely linked to angiogenesis (reviewed in Bouck et al., 1996) . The neovascularization or angiogenesis is critical to the initial tumor growth and is an important event leading to metastatic dissemination of cancer (Folkman, 1990; Risau 1997) . Several potential stimulators of angiogenesis have been identi®ed to be produced by tumor cells themselves or the surrounding stromal cells (Hanahan and Folkman, 1996; Fukumura et al., 1998) . Vascular endothelial growth factors (VEGFs) and certain FGFs are the best characterized angiogenic molecules (reviewed in Gerwins et al., 2000) . From 23 FGF family members, only FGF-1, -2, -3, and -4, have previously been found to be produced by tumor cells and induce angiogenesis in vivo (reviewed in Bouck et al., 1996) .
We have used Shionogi 115 (S115) mouse breast cancer cells as a model in studies of hormone-regulated malignant growth (HaÈ rkoÈ nen et al., 1990) . S115 cells express a transformed phenotype when cultured in the presence of androgen (Darbre and King, 1988) . Androgen has also been shown to enhance the angiogenic ability of Shionogi 115 carcinoma (Takatsuka et al., 1992) . On the basis of our experimental data (Ruohola et al., 1995) and other reports (Tanaka et al., 1992; Yamanishi et al., 1995) , it has been concluded that the androgen-induced growth of S115 cells is mediated through the induction of autocrine growth factor(s), probably mainly FGF-8. This study was undertaken to elucidate the role of FGF-8 isoforms in growth, tumor formation and angiogenic capacity of androgen-dependent S115 mouse mammary tumor cells. The S115 cell lines transfected with the expression vectors of cDNA encoding FGF-8a, -8b, and -8e were investigated for their growth properties in vitro and angiogenic and tumorigenic capacity in vivo. Angiogenic capacity of FGF-8b was further studied with in vitro and in vivo models of vessel formation. Our results show that at least FGF-8 isoform b, and possibly isoform a, belong to those members of the FGF family which have an angiogenic capacity. The results further demonstrate that FGF-8b is able to mediate androgen eects on S115 breast cancer cell morphology and proliferation in vivo and in vitro.
Results

FGF-8 antisense oligonucleotides inhibit the androgen-induced growth of S115 cells
Our previous studies (Ruohola et al., 1995) , as well as those of others (Tanaka et al., 1992; Yamanishi et al., 1995) , have shown that S115 cells secrete FGF-8, when they are stimulated with testosterone (T). The role of FGF-8 in the proliferation of S115 cells was studied by incubating the cells with speci®c antisense oligonucleotides designed to encompass the FGF-8 translation initiation site. In the presence of FGF-8 antisense oligonucleotides, T-induced DNA-synthesis of S115 cells was inhibited to the level of control in 24 h, whereas sense and random sense oligonucleotides did not have any signi®cant eect (Figure 1a ). FGF-8 antisense oligonucleotides decreased the level of mRNA for FGF-8, but not for FGF-7 (KGF) in testosterone-stimulated S115 cells, which indicates their speci®city for FGF-8 (Figure 1b) . The results suggested that induction of FGF-8 was involved in T-induced stimulation of growth, but the role of dierent isoforms remained open in this experiment. + RNA from S115 cells cultured in the presence of 10 nM T (T+) and FGF-8 antisense (AS+) or sense (S+) oligonucleotides for 3 days. S115 cells grown in the absence of T was used as a control (T-). Relative levels of FGF-8 and FGF-7 mRNAs [FGF/ oligo(dT) 15 ; scanning units] are shown below by columns FGF-8 isoforms a, b, and e are expressed in S115 cells
The expression of dierent isoforms of FGF-8 in S115 cells cultured in the presence of T was studied with RT ± PCR by using the primers detecting all known isoforms (Ghosh et al., 1996) . We found that S115 cells express FGF-8 isoforms a, b, and e. The isoform b was the most abundant and the isoform e seemed to be expressed at the lowest level (Figure 2a) . In order to study the putative role of endogenously expressed FGF-8 isoforms in the androgen-dependent malignant phenotype, we constitutively over-expressed them in wild type S115 cells. The expression plasmid pLTRpoly containing the coding sequences for Fgf-8a, -b, or -e under the transcriptional control of MoMLV ± LTR promoter was transfected into S115 cells. The plasmid without cDNA (Mock) was used as a negative control. G418 resistant clones of Fgf-8a-, Fgf-8b-, or Fgf-8e-transfected and Mock-transfected S115 cells were isolated, and the expression of transfected Fgf-8 gene was con®rmed by Northern blot analysis of the cells grown with or without T (Figure 2b ,c). Three to four dierent clones of Fgf-8a-(a7, a17, and a18), Fgf-8b-(b1, b3, b12, and b14), Fgf-8e-(e6, e12, and e16), and Mock-transfected (m1, m3, and m4) cells were selected for further analysis.
All isoforms were constitutively over-expressed both in the presence and absence of T, although there were dierences in the expression levels of various isoforms. The level of the mRNA for transfected Fgf-8 was in some clones increased by T. As one of the possible mechanisms, this may be caused by the integration of transfected DNA near the hormone responsive elements/sites in the chromosomal DNA. Expression vector pLTRpoly itself does not contain hormone responsive ARE or AP-1 consensus elements (MaÈ kelaÈ et al., 1992) . Another possibility is that androgen aects the turnover rate of FGF-8 mRNA (among other mRNA species). Repeated experiments using the clones of dierent isoforms expressing the levels of FGF-8 mRNA (Figure 2c ), which are comparable to each other, were performed in order to demonstrate that the eects of FGF-8b were not dependent on the expression level only. Mock-transfected or wild type S115 cells did not express FGF-8 when cultured in the absence of T.
The effects of FGF-8a, -8b, and -8e on the morphology and proliferation of S115 cells
The growth characteristics and hormone regulation of transfected cells were ®rst studied by culturing them in the presence or absence of T. Parental S115 mouse mammary tumor cells are ®broblastic in the presence of T, but removal of androgen induces a transition from ®broblastic to epithelial-like morphology (Yates and King, 1981) . FGF-8b over-expressing cells were ®broblastic, rounded and poorly attached to culture dishes both in the presence and absence of T, whereas FGF-8a and FGF-8e over-expressing cells or Mock cells were similar to S115 cells (Figure 3) .
The proliferation of FGF-8b-S115 cells, compared to Mock or S115wt cells, was markedly increased when they were cultured in the absence of T, and they proliferated actively in an androgen-independent manner (Figure 4 ). In T-containing medium the rate b3, b12, b14) , a17, a18) , FGF-8e (e6, e12, e16) transfected S115 cells or Mock (m1, m4) and S115wt (wt) cells cultured with or without 10 nM T. The positions of transfected and endogenous FGF-8 mRNAs are shown on the right. The corresponding ethidium bromide (EtBr) stainings of the RNAs are shown in the lower panels as loading controls. (c) Northern blot analysis of RNA (20 mg) from the cell lines expressing roughly comparable levels of FGF-8 mRNA when cultured in the absence of T of proliferation was not higher than that of the control cells suggesting that FGF-8b was able to confer an androgen-independence of proliferation to the cells. The proliferation of FGF-8a-and FGF-8e-transfected S115 cells was clearly stimulated by T and thus similar to that of Mock or S115wt cells.
FGF-8b over-expression induces anchorage-independent growth of S115 cells
The acquisition of anchorage-independent growth is generally considered as one of the in vitro properties associated with the transformed/malignant phenotype of the cells. The transfected cells were examined for their ability to grow in suspension and soft agar cultures without T. Parental S115 cells are able to proliferate in suspension culture in the presence of T, but not in its absence (Darbre and King, 1987; HaÈ rkoÈ nen et al., 1990) . FGF-8b-transfected S115 cells, but not FGF-8a-, FGF-8e-, or Mock-transfected cells, were able to proliferate in the absence of T in the suspension culture (Figure 5a ). At day 10 the cell number of FGF-8b over-expressing S115 clones (b3, b14) was 4 ± 9-fold when compared to the cell numbers of the corresponding clone at day 0, whereas the numbers of FGF-8a-(a17, a18), FGF-8e-(e6, e12), or Mock-transfected (m3, m4) cells rather decreased. FGF-8b over-expressing cells formed large colonies in which the cells were very loosely attached to each other. In addition, there were also many single cells. FGF-8a-, FGF-8e-, and Mock-transfected cells formed only small cell aggregates (Figure 5b ). In soft agar clonogenicity assays of FGF-8b-transfected cells (b1, b12, b14), the colony forming eciency (CFE) was 3.5+2.1%, whereas that of FGF-8a (a7, a18), FGF-8e (e6, e16), and Mock (m1, m4) cells was markedly lower (1.3+0.6%, 0.5+0.45%, and 0.15+0.15%, respectively) (data not shown).
FGF-8b over-expression accelerates tumor growth
To investigate the tumorigenicity of the transfected cell lines, the cells were transplanted s.c. into BALB/c nude mice. FGF-8b-S115 cell clones (b1, b3, b12, and b14) produced large tumors in 2 weeks (size on the day of sacri®ce 696+472 mm 3 ; mean+s.e.m.) ( Figure  6b ), with an average tumor latency of less than 6 days. Another experiment was performed in order to compare the eect of the expression level of transfected Fgf-8b gene on the tumor growth but we could not ®nd any obvious correlation with the expression level and tumor growth. Both the transfected clones expressing lower levels of FGF-8b mRNA (b1, b12), and the clones with higher FGF-8 mRNA levels (b3, b14), eectively produced tumors ( Figure 6b ).
FGF-8a-S115 cell clones (a7, a17, and a18) produced tumors (size 293+179 mm 3 ) with a longer period of latency than FGF-8b-S115 cells (1 ± 9 weeks) ( Figure  6a ) but in comparison with the controls, tumor growth was stimulated. The growth of FGF-8e tumors did not markedly dier from that of the tumors derived from control cells. The latency period of the tumors produced by FGF-8e-expressing cell clones (e6, e12, and e16) (size 267+113 mm 3 ) was 4 ± 8 weeks ( Figure  6c ). The latency period of the tumors formed by Mock and parental S115 cells varied from 1 ± 6 weeks and their mean size at the end of the experiment was 120+96 mm 3 ( Figure 6d ). The tumor intake of FGF8b-, FGF-8a-, and FGF-8e-transfected, or control cells (Mock-transfected and parental cells) was 100% (30/ 30), 83% (20/24), 75% (12/16), and 70% (17/24), respectively. We did not ®nd any signs of macrometastasis to lungs, liver, or spleen in any of the implanted mice.
Increased angiogenesis in FGF-8b over-expressing tumors
Morphological examination of the hematoxylin-eosin (H&E) stained sections of the FGF-8b over-expressing tumors showed an overall angiogenic morphology containing numerous large sinusoid-like vessels and small capillaries (Figure 7b ). Most strikingly, in addition to apparently normal blood vessels, tumors derived from FGF-8b over-expressing cells contained large, peculiar, cisternal spaces, which were ®lled with Vascularization was quanti®ed by measuring the relative areas of vessels from three ®elds of the most vascularized areas per tumor. There was a signi®cant increase in the area covered by vessels in the FGF-8b tumors, when compared with the tumors derived from FGF-8a, FGF-8e, or control cells (P=0.043, P=0.002, and P=0.002, respectively) ( Figure 7e ). The area of vessels in FGF-8a expressing tumors seemed to be increased, but the dierence from that in control tumors was not statistically signi®cant. All tumors produced by FGF-8a, -8b, and -8e transfectants were found to express FGF-8 mRNA but there were marked dierences between the expression levels of individual tumors (Figure 7f ). FGF-8 mRNA expression was generally high in FGF-8b-transfected tumors, which all showed angiogenic morphology and increased growth rate. Actually, FGF-8b-transfected cells expressing lower levels of FGF-8b (b1 and b12) (Figure 2c ) formed tumors which were by gross morphology similar to those formed by the clones with higher FGF-8b expression (b3 and b14) (data not shown). However, although FGF-8 mRNA was expressed at a high level also in the tumors of FGF8e-transfected cells their growth rate or vessel density was not increased. Taken together, the results demonstrate that the over-expression of FGF-8b in S115 mouse mammary tumor cells increases tumor growth and vascularization of the tumors in nude mice.
Induction of angiogenic responses in IBE cells
The angiogenic capacity of FGF-8b was studied next by using immortomouse brain capillary endothelial cells (IBECs). We used commercial rFGF-8b protein, which is not glycosylated. In mitogenicity assays the rFGF-8b has been found to be a more eective activator of FGFRs than natural glycosylated FGF8b (MacArthur et al., 1995b) . The rFGF-8b stimulated the proliferation of IBECs in a dose-dependent manner. The maximum stimulation was obtained at the concentration of 100 ng/ml (Figure 8a ). The rFGF-2 was a more potent mitogen for endothelial cells than rFGF-8b. The mitogenic eect of heparin binding growth factors (HBGFs) fraction-ated from S115 cell conditioned medium (Ruohola et al., 1995) was also evident. Stimulation of endothelial cell proliferation by rFGF-8b, rFGF-2 and S115-HBGF was found to be statistically signi®cant (P40.01). The rFGF-8b was also able to stimulate migration of IBECs through a porous membrane (Figure 8b ) (P40.01). The rFGF-2, used as a positive control, had a clear and powerful stimulatory eect on migration of IBE cells (P40.01) as shown before (Kanda et al., 1996) .
In vitro angiogenesis studies on collagen gel showed that rFGF-8b promoted endothelial cell dierentiation in the tube-formation assay. On collagen gel, rFGF-8b (25 ng/ml) induced organization of IBECs to cords, which surrounded lumen-like structures (Figure 8c ). They were similar to those formed in the presence of rFGF-2 (10 ng/ml) used as a positive control ( Figure  8b ). The control IBE cells grown without growth factor addition mainly detached from the gel and underwent apoptosis.
FGF-8b induces angiogenic response in vivo in CAM assay
The angiogenetic potential of rFGF-8b was studied next in vivo in chorion allantoic membrane (CAM) assay (Auerbach et al., 1974) . The rFGF-8b (50 mg/ml) induced more vessel sprouts than the negative control (PBS) did (Figure 9 ). However, FGF-2 (50 mg/ml) seemed to be more potent in this respect. Vessel density was higher around the ®lters saturated with FGF-8b or FGF-2 when compared to control ®lters (PBS). This clearly demonstrated the angiogenic potential of FGF8b in vivo.
Discussion
Our results show, for the ®rst time, that FGF-8 is an angiogenic growth factor. This property probably greatly contributes to its stimulatory eect on tumor growth. Our results further demonstrate that FGF-8b is the most potent FGF-8 isoform in promoting vessel formation. It is also able to confer a hormone independence of the in vivo and in vitro growth to androgen-regulated S115 mouse mammary tumor cells.
The three isoforms endogenously expressed by S115 cells clearly diered in their angiogenic capacity. The tumors produced by FGF-8b over-expressing cells were found to have a very angiogenic morphology with a great number of large dilated vessels. The relative area covered by vessels in FGF-8b tumors was larger than that in FGF-8a, FGF-8e, or Mock and S115 wild type tumors. The tumors formed by FGF-8a-transfected cells were also apparently more vascular than control tumors, but the dierence between the relative vascular areas was not statistically signi®cant. It is thus possible that the eect of FGF-8a is primarily targeted on endothelial cells, which could explain the stimulation of growth in FGF-8a tumors. If this was the case, FGF8a might function synergistically with other endogenously expressed FGF-8 isoforms in vivo to promote S115 tumor growth. The level of FGF-8a mRNA in transfected cells and tumors was lower than that of FGF-8b which may aect the relative activity. However, we believe that the dierential eects on proliferation and tumor vascularization re¯ect true dierences in the biological activities of the isoforms. This conclusion is based on the following observations presented in this work: First, in each clone studied the level of transfected FGF-8 mRNA was higher than the level of endogenous FGF-8 mRNA expressed in the presence of androgen under which conditions the transformed phenotype is expressed. Second, all S115-FGF-8b clones, although expressing dierent levels of FGF-8b mRNA, very rapidly produced large wellvascularized tumors. Third, FGF-8e was expressed at a high level in both transfected cells and the tumors derived from them but the tumors were not highly vascularized.
The microscopical analysis of tumor vasculature revealed the presence of rich vascular bed in FGF-8b Abnormal vascularization has also previously been found in tumors produced by FGF-1-transfected NBT-II cells (Jouanneau et al., 1995) . Very recently, similar abnormal vessels have been found in various types of cancers, such as uveal melanomas and colon carcinomas (Maniotis et al., 1999; Chang et al., 2000) . However, it is still possible that endothelial cells line the vessel walls but that they are very thin and poorly visible and need to be studied further with other methods such as electron microscopy. Taken together, it is possible that FGF-8b is not able to induce proper vessel formation alone, but other factors are also required. It has been shown that FGF-2 acts synergistically with VEGF in the induction of angiogenesis in vitro (Pepper et al., 1992; Goto et al., 1993) . We have previously shown that androgen also induces the expression of VEGF in S115 cells (Ruohola et al., 1999) . FGF-8 is thus a potential candidate for synergistic action with VEGF. However, the interesting possibility of the cooperation of VEGF and FGF-8 in the growth of S115 tumors remains to be studied. The angiogenic capacity of FGF-8 protein was con®rmed in in vitro and in vivo angiogenesis models using immortomous brain capillary endothelial cells (IBECs) and a CAM assay, respectively. Recombinant FGF-8b protein was found to stimulate proliferation, migration and sprouting of endothelial cells in vitro. It also showed angiogenic potential in a CAM assay in vivo. To our knowledge, this is the ®rst report on the angiogenic capacity of FGF-8. The rFGF-8b is not glycosylated as the natural protein but it is, however, able to interact with FGFRs. Actually, rFGF-8b is possibly even more active than native FGF-8b (MacArthur et al., 1995b) . However, endothelial cell proliferation was also stimulated by heparin-binding growth factors isolated from the conditioned medium of S115 cells, suggesting that natural FGF-8 has similar stimulatory eects. In clinical breast cancer, increased angiogenesis has been found to correlate independently with poor prognosis of disease (Weidner et al., 1992; Toi et al., 1995; Hansen et al., 2000) . Besides VEGF, which has been proved to correlate with increased angiogenesis (Guidi et al., 1997) and poor prognosis of breast cancer (Toi et al., 1994; Gasparini et al., 1997; Relf et al., 1997) , the level of FGF-8 expression has been found to be increased in breast cancer . Thus, it is possible that FGF-8 contributes to tumor formation and progression not only as an autocrine mitogenic factor but also as a paracrine angiogenic factor.
Our results showed that androgen-induced proliferation of S115 cells is inhibited by FGF-8 antisense oligonucleotides which supports the earlier conclusions (Sato et al., 1993; Ruohola et al., 1995; Yamanishi et al., 1995) that FGF-8 is important in the mediation of MacArthur et al., 1995a; Ghosh et al., 1996) . In our experiments, transfection of FGF-8b into S115 cells resulted in androgen-independent growth of cells both in anchorage-dependent and anchorage-independent cultures, whereas FGF-8 isoforms a and e seemed to be rather inactive in vitro. Variation in biological activity of the FGF-8 isoforms may be related to their dierential FGF receptor binding capacities. In transfection assays FGF-8b activates the c splice forms of FGFR-2, FGFR-3 and FGFR-4 (Blunt et al., 1997) . It has also been shown to activate FGFR-1c at micromolar concentrations (Kouhara et al., 1994; MacArthur et al., 1995b) . FGF-8a has not been found to activate any of the known FGF receptor forms (MacArthur et al., 1995b) . FGF-8e activates FGFR-3c and FGFR-4, but not FGFR-2c (Blunt et al., 1997) . We have previously shown that S115 cells express mRNA for FGFR-1, FGFR-2 and FGFR-3 (Ruohola et al., 1995). The splicing forms expressed are not known but the response of S115 cells to FGF-8 suggests that the c splicing forms of two or several of the receptors are most probably expressed. Thus FGFR-1c, FGFR-2c and FGFR-3c are the putative receptors for FGF-8b in these cells. FGFR-3 could be the receptor for FGF-8e in S115 cells, but in this study we did not ®nd any eect of FGF-8e on these cells. The signaling route of FGF-8a remains unclear, but we report here an obvious response of tumor growth and, possibly, of angiogenesis to FGF-8a. It is possible, as suggested by MacArthur and co-workers (MacArthur et al., 1995b) , that FGF-8a activates an as yet unknown receptor. Our results are also in line with previous studies (MacArthur et al., 1995a; Ghosh et al., 1996) which reported a moderate increase in tumor growth of FGF-8a-transfected NIH3T3 cells. Taken together, these results and earlier reports show that FGF-8 is an obligatory component in androgen-induced autocrine loop in S115 cells. We demonstrate here that various FGF-8 isoforms induced by testosterone treatment in S115 cells dierentially contribute to this eect.
The loss of hormone-responsiveness is a major problem in the treatment of hormonal cancer, such as breast cancer. This is often associated with hormone-independent activation of growth factor production, which leads to constitutive growth stimulation (Dickson and Lippman, 1995; Nicholson and Gee, 2000) . Activation of VEGF expression has been found to be responsible for the relapsed growth of Shionogi tumors after gonadectomy . This suggests a very important role for these androgen-induced growth factors in the conversion of a hormone-dependent phenotype of cancer cells to a hormone-independent one. These factors may have originally been targets for hormone action but lost hormone-sensitivity upon tumor progression. In S115 cells, FGF-8 and its transforming eects are induced by androgens via the LTR of the MMTV sequences integrated close to the FGF-8 gene (Valve et al., 1998) . FGF-8 is thus not a truly hormone-responsive gene and a mediator of androgen action in nontransformed mammary epithelium but the hormonedependence of of FGF-8 gene in S115 cells and tumors is an acquired capacity. The cell line provides, however, a useful model for hormone-regulated malignant growth and over-expression of FGF-8b may represent a good example of the mechanisms by which activation of a particular growth factor expression is able to overcome hormone regulation and to lead to hormone-independent growth. Fgf-8 could be such a gene also in clinical hormonal cancer since expression of various FGF-8 isoforms has recently been shown to be induced or increased in breast , prostate (Dorkin et al., 1999; Wang et al., 1999) , and ovarian cancer (Valve et al., 2000) . Activation of FGF-8 isoforms with their dierential autocrine and paracrine capacities may 
Materials and methods
Cell culture
The mouse mammary tumor S115 cell line (HaÈ rkoÈ nen et al., 1990) was maintained in DMEM culture medium supplemented with 4% heat-inactivated fetal bovine serum (iFBS), 10 nM testosterone (T), 1 mM L-glutamine and 1 mM pyruvate. For RNA analysis, cells were cultured in DMEM with 4% dextran charcoal-treated (DC) FBS. FBS and pyruvate were purchased from Gibco BRL (Paisley, UK), L-glutamine from Fluka (Riedel de-HaeÈ n, Germany) and T (4-androsten-17-ol-3-one) was from the Sigma Chemical Co. (St. Louis, MO, USA).
For determination of anchorage-dependent growth, cells (2610 4 ) were seeded into 6-well plates (Nunc, Roskilde, Denmark) in DMEM with 2% DC-FBS without any hormones. The next day medium was changed, and T (10 nM) was added. On the days indicated, cell numbers were determined by counting cell nuclei in a Coulter Counter (Coulter, Harpenden, UK) as we have previously described (Ruohola et al., 1995) .
For determination of anchorage-independent growth, cells (4610 4 ) in liquid suspension culture were grown in DMEM with 2% DC-FBS without T in 30-mm plastic bacteriological dishes to which less than 2% of the cells could attach (Sterilin, UK). On the days indicated, cells were harvested and counted as for monolayers except that lysis took about 1 h with gentle rocking of the colonies. Soft-agar colony formation eciency was assayed as previously described (LeppaÈ et al., 1992) without T with minor modi®cations. Cells (2610 4 ) were cultured for 3 weeks, after which colonies 450 mm were counted. IBE (immortomouse brain capillary endothelial) cells were kindly donated by Professor Lena Claesson-Welsh, University of Uppsala, Sweden. These cells were primarily isolated from H-2Kb-tsA58 transgenic mice (Kanda et al., 1996) . IBECs were grown on 0.1% gelatin-coated plastic tissue culture dishes and were maintained in Ham's F12 culture medium (Gibco BRL, Paisley, UK) with 10% iFBS and 20 U/ml IFN-g (R&D-Systems, UK).
Inhibition of proliferation with FGF-8 oligonucleotides
The sequences of FGF-8 antisense, sense and randomly selected sense phosphorothioate oligonucleotides used in the study, designed to encompass the translation initiation site, were as follows: 5'-CGCGCCATGGGCAGCCCC-3' (sense); 5'-GGGGCTGCCCATGGCGCG-3' (antisense); 5'-GCATG-CTAGCTTCGATCG-3' (random sense). The concentration of 0.5 mM was found to be optimal to obtain speci®c eects. 
PCR cloning of FGF-8 isoforms and construction of expression vectors
To detect and separate all FGF-8 isoforms expressed in S115 cells, we used a set of primers according to Ghosh et al. (1996) , and with these primers FGF-8-a, -b, and -e isoforms were detected. As a gift from Dr P Roy-Burman (University of Southern California School of Medicine, Los Angeles, USA) we got FGF-8 isoform b cDNA in the expression vector pcDNA3 (Invitrogen, The Netherlands) (Ghosh et al., 1996) . FGF-8b cDNA was subcloned to EcoRI site in pLTRpoly mammalian expression vector under the control of MoMLV ± LTR promoter (MaÈ kelaÈ et al., 1992) . The coding region of FGF-8 was ampli®ed from RNA of S115 cells as previously described (Ruohola et al., 1995) and the isoforms a and e were detected. The cohesive ends of RT ± PCR products were ®lled with Klenow enzyme (Amersham Pharmacia Biotech), nucleotide blunt ended, kinased with T 4 -poly-nucleotide kinase (Amersham Pharmacia Biotech), and digested with EcoRI. The resulting RT ± PCR products (FGF-8a, FGF-8b, and FGF-8e) were ligated to pLTRpoly vector, which was digested with SmaI (5', blunt end) and EcoRI (3') restriction enzymes. All FGF-8 isoforms were sequenced with ABI PRISM 2 100, version 3.2.
Transfection of S115 cells with FGF-8 expression vectors
Eukaryotic expression vector pLTRpoly (MaÈ kelaÈ et al., 1992) which contained the coding regions of FGF-8a, FGF-8b, or FGF-8e, as well as a selection vector pSV2-neo (Southern and Berg, 1982) , were co-transfected into S115 cells by using Lipofectin (Gibco BRL, Paisley, UK) according to the manufacturer's instructions. pLTRpoly and pSV2-neo were kind gifts from Professor Kari Alitalo, Molecular/Cancer Biology Laboratory, University of Helsinki. Co-transfection with empty pLTRpoly and pSV2-neo served as a control (Mock). Cells were selected for stable transfection with normal culture medium containing 750 mg G418 Sulfate/ml (Calbiochem, Germany) for 14 days. Isolated colonies were cloned and characterized after expansion of the clones.
RNA isolation and Northern blot analysis
Total RNA was extracted using the guanidinium isothiocyanate method (Chomczynski and Sacchi, 1987) . Poly(A) + RNA was isolated as previously described (Hartmann et al., 1990) . Samples of RNA (20 mg) or poly(A) + RNA (5mg) were separated by electrophoresis and blotted on Gene Screen Plus nylon membrane (NEN 1, Research Products, Boston, MA, USA) using standard conditions. The PCR clone for FGF-8 (Ruohola et al., 1995) or the rat FGF-7 cDNA (Yan et al., 1991) (Harley, 1987) was used as a control for poly(A) + RNA loading. Hybridization was carried out in standard conditions. The intensities of hybridization signals were quantitated by densitometry, using an MCID Image Analyzer (Imaging Research Inc., MCID M4).
Tumorigenicity studies
Tumorigenicity was examined by inoculation of 2.5610 6 or 5610 6 cells s.c. into the neck of 6-to 7-week-old athymic male mice (Balb/cABom-nu/nu; BomholtgaÊ rd, Denmark). Tumor measurements were performed twice a week. The tumors were measured in two dimensions, and the volumes were calculated according to the formula V=(p/6)(d 1 6d 2 ) 3/2 , where d 1 and d 2 are two perpendicular tumor diameters (WaÈ rri et al., 1993) . At the end of the experiment, the animals were killed in a CO 2 chamber and tumors were quickly removed and divided into two parts. One half was ®xed in formalin for histologic examination and the other half was frozen for RNA analysis.
Determination of tumor angiogenesis
The maximal areas of neovascularization were identi®ed by microscope by scanning tumors at low magni®cation (640). Three separate non-overlapping ®elds (magni®cation 6100 ± 200) from highly vascularized areas were captured and stored in a microcomputer by using a Kappa CF8/1 FMC digital camera. The relative areas of existing vessels (in pixels) in the three separate ®elds were measured by using Adobe Photoshop version 5.
Endothelial cell proliferation assay IBE cells were plated (35 000 cells/well) on gelatinized 24-well culture plates in Ham's F12 medium supplemented with 10% iFBS and IFN-g (20 U/ml) and incubated for 24 h. Next day the starvation medium, Ham's F12 with 0.2% BSA, was changed to the cells. Forty-eight hours later, the cells were stimulated with rFGF-2 (5 and 10 ng/ml) (Sigma Chemical Co., St. Louis, MO, USA) and rFGF-8b (25, 50, and 100 ng/ ml) (R&D Systems, Minneapolis, MN, USA). Starvation medium without growth factors was used as a control. HBGF (heparin binding growth factors) extracted from the conditioned media of Shionogi 115 cells (Ruohola et al., 1995) was also tested for its mitogenicity in IBE cells. In addition to FGF-8b and small amounts of VEGF and FGF-2, HBGF from S115 cells contains other isoforms of FGF-8, namely FGF-8a and FGF-8e (Ruohola et al., 1995 , and data not shown). Cell numbers were determined by using a Coulter counter after 24 h of incubation.
Endothelial cell migration assay
Endothelial cell migration was studied on Transwell plates with Falcon 1 cell culture inserts (Becton Dickinson Labware Europe, France). The inserts were coated with 20% iFBS for 2 h in a cell culture incubator. Ham's F12 medium supplemented with 0.2% BSA and FGF-2 (Sigma) 10 ng/ ml, FGF-8b (R&D Systems) 25 ng/ml or nothing (control) were added to the bottom of the wells. IBE cells (1610 5 / insert) were plated on the inserts in Ham's F12 with 0.2% BSA. Cells were let to migrate for 24 h, washed with PBS, ®xed with 4% paraformaldehyde, and stained with hematoxylin. Cells that had penetrated through porous membrane were counted per ®eld. Three ®elds per insert were examined.
Endothelial cell differentiation assay
Dierentiation, i.e. organization of endothelial cells into lumen-like structures, was studied on collagen gel. Collagen gel was composed of type I collagen (Collaborative Biomedical Products, Becton Dickinson Labware, Bedford, MA, USA), 106 Ham's F12 medium, and 0.1 M NaOH in ratio of 8 : 1 : 1, and was allowed to gel in cell culture incubator. IBECs (3.5610 5 /well) were plated on the gel in starvation medium in 6-well plates and allowed to adhere before the growth factors (FGF-2 10 ng/ml and FGF-8b 50 ng/ml) were added. After a 24 h incubation, the dierentiation response was examined under a microscope and photographed.
CAM assay
In vivo angiogenesis studies were performed by using a CAM (chorion allantoic membrane) assay (Auerbach et al., 1974) . Three-day-old eggs of White leghorn chicken were cracked onto petri dishes and embryos were incubated at +378C with relative humidity for 2 days. On embryonic day 6, round ®lters (Whatman 3MM, 6 mm in diameter) saturated with FGF-8b 50 mg/ml or with FGF-2 50 mg/ml were applied to the chorion allantoic membrane of the chicken embryo. PBS was used as a control. The angiogenic response around the ®lters was observed 5 days later under a stereomicroscope and photographed.
Statistical analysis
The statistical signi®cance of dierences in vessel area was assessed by one-way ANOVA. ANOVA followed by Duncan multiple-range test and Mann-Whitney U-test were used to compare statistical dierence in IBE cell proliferation and migration assays, respectively. Statistical signi®cance was based on P values50.05.
